|Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact|
Click weeks 0 - 40 and follow fetal growth
Fresh Embryos May Improve Assisted Reproduction
Air Pollution Link to Diabetes and Hypertension in African-American Women
Poor Maternal Diet Can Increase Risk of Diabetes
Is Obesity in Infants “Programmed” in the Womb?
Progress Towards a Genital Herpes Vaccine
Rare Liver Disorder Kids Tolerate Mom's Graft Best
Simple Blood Test in First Trimester Reveals Gender
Nap-deprived Tots Missing Out On More Than Sleep
Women Susceptible to Infection When Ovulating
Gestational Diabetes Linked To Risk of ADHD
Physical Activity, School Performance May Be Linked
Evolution Reveals Missing Link in DNA/Protein Shape
Bacteria Fights Fluoride in Toothpaste and in Nature
Gene Identified in Risk for Pancreatic Cancer
Mutations in the ATM gene may increase the hereditary risk for pancreatic cancer, according to data published in Cancer Discovery, the newest journal of the American Association for Cancer Research.
Pancreatic cancer is one of the most morbid cancers, with less than 5 percent of those diagnosed with the disease surviving to five years. Approximately 10 percent of patients come from families with multiple cases of pancreatic cancer.
"There was significant reason to believe this clustering was due to genetics, but we had not, to this point, been able to find the causative genes that explained the cluster of pancreatic cancer for a majority of these families," said lead author Alison Klein, Ph.D., associate professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and director of the National Familial Pancreas Tumor Registry.
Klein and colleagues used next-generation sequencing, including whole genome and whole exome analyses, and identified ATM gene mutations in two kindreds with familial pancreatic cancer.
When these initial findings were examined in a large series for patients, ATM mutations were present in four of 166 subjects with pancreatic cancer but were absent in 190 spousal control subsets.
Klein said that knowledge of the presence of the ATM gene could lead to better screening for pancreatic cancer, the fourth most common cause of cancer-related death.
However, there are currently no recommended screening tests.
Many doctors use endoscopy as a screening tool for pancreatic cancer, but researchers are still evaluating this technique in clinical trials.
Follow the AACR on Twitter: @aacr #aacr
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 laboratory, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries.
Original article: http://www.eurekalert.org/pub_releases/2011-12/aafc-gii122711.php